Related Experiment Videos
Bioconversion of compactin into pravastatin by Streptomyces sp
Joo-Woong Park1, Joo-Kyung Lee, Tae-Jong Kwon
1Biotechnology Laboratory, Youngjin Pharmaceutical Co. Ltd., Pyungtaek-Si 451-860, Korea.
Biotechnology Letters
|December 18, 2003
Abstract:
Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l(-1) from 750 mg compactin l(-1) in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l(-1) and 1000 mg pravastatin l(-1), respectively, with the conversion rate of 10 mg l(-1) h(-1). Continuous feeding of compactin increased production of pravastatin to 15 mg l(-1) h(-1).